Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 8 studies | 28% ± 11% |
Insufficient scRNA-seq data for expression of CHST6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1361.79 | 2641 / 2642 | 88% | 11.30 | 622 / 705 |
adrenal gland | 100% | 1789.83 | 257 / 258 | 15% | 3.14 | 35 / 230 |
skin | 20% | 48.01 | 353 / 1809 | 86% | 11.91 | 407 / 472 |
esophagus | 66% | 204.36 | 947 / 1445 | 35% | 1.54 | 64 / 183 |
lung | 49% | 299.94 | 282 / 578 | 51% | 3.89 | 587 / 1155 |
intestine | 76% | 242.37 | 736 / 966 | 18% | 1.09 | 93 / 527 |
blood vessel | 92% | 395.08 | 1230 / 1335 | 0% | 0 | 0 / 0 |
uterus | 8% | 101.20 | 13 / 170 | 54% | 7.78 | 246 / 459 |
heart | 60% | 273.32 | 517 / 861 | 0% | 0 | 0 / 0 |
prostate | 54% | 124.57 | 133 / 245 | 1% | 0.03 | 3 / 502 |
ovary | 0% | 0 | 0 / 180 | 47% | 3.50 | 204 / 430 |
eye | 0% | 0 | 0 / 0 | 45% | 1.39 | 36 / 80 |
pancreas | 2% | 3.16 | 5 / 328 | 38% | 1.85 | 68 / 178 |
tonsil | 0% | 0 | 0 / 0 | 36% | 3.80 | 16 / 45 |
bladder | 5% | 7.10 | 1 / 21 | 22% | 1.31 | 112 / 504 |
breast | 1% | 1.80 | 5 / 459 | 20% | 0.98 | 219 / 1118 |
stomach | 7% | 11.72 | 26 / 359 | 13% | 0.66 | 36 / 286 |
peripheral blood | 13% | 41.00 | 121 / 929 | 0% | 0 | 0 / 0 |
thymus | 1% | 0.89 | 4 / 653 | 7% | 0.41 | 43 / 605 |
kidney | 4% | 11.70 | 4 / 89 | 1% | 0.19 | 13 / 901 |
liver | 1% | 1.60 | 2 / 226 | 1% | 0.03 | 3 / 406 |
muscle | 1% | 3.93 | 12 / 803 | 0% | 0 | 0 / 0 |
adipose | 1% | 3.23 | 17 / 1204 | 0% | 0 | 0 / 0 |
spleen | 0% | 1.26 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0006044 | Biological process | N-acetylglucosamine metabolic process |
GO_0006790 | Biological process | sulfur compound metabolic process |
GO_0018146 | Biological process | keratan sulfate biosynthetic process |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0045130 | Molecular function | keratan sulfotransferase activity |
GO_0001517 | Molecular function | N-acetylglucosamine 6-O-sulfotransferase activity |
Gene name | CHST6 |
Protein name | Carbohydrate sulfotransferase 6 (Corneal N-acetylglucosamine-6-O-sulfotransferase) (C-GlcNAc6ST) (hCGn6ST) (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta) (GST4-beta) (N-acetylglucosamine 6-O-sulfotransferase 5) (GlcNAc6ST-5) (Gn6st-5) Sulfotransferase (EC 2.8.2.-) Alternative protein CHST6 Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 |
Synonyms | |
Description | FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues of keratan . Cooperates with B4GALT4 galactosyltransferase and B3GNT7 N-acetylglucosaminyltransferase to construct and elongate the sulfated disaccharide unit [->3Galbeta1->4(6-sulfoGlcNAcbeta)1->] within keratan sulfate polymer. Involved in biosynthesis of keratan sulfate in cornea, with an impact on proteoglycan fibril organization and corneal transparency . Involved in sulfation of endothelial mucins such as GLYCAM1 . . |
Accessions | A0A1I9LHJ2 ENST00000332272.9 ENST00000649824.1 D6QZA2 L8E925 A0A1I9LHJ1 ENST00000649341.1 ENST00000390664.3 D6QZA0 A0A1I9LHJ0 D6QZA1 Q9GZX3 |